Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Shares, $0.001 par value
-
Shares outstanding
-
104M
-
Number of holders
-
82
-
Total 13F shares, excl. options
-
27.6M
-
Shares change
-
+1.28M
-
Total reported value, excl. options
-
$462M
-
Value change
-
+$22.9M
-
Number of buys
-
52
-
Number of sells
-
-33
-
Price
-
$16.71
Significant Holders of BlackRock Health Sciences Term Trust - Common Shares, $0.001 par value (BMEZ) as of Q1 2023
95 filings reported holding BMEZ - BlackRock Health Sciences Term Trust - Common Shares, $0.001 par value as of Q1 2023.
BlackRock Health Sciences Term Trust - Common Shares, $0.001 par value (BMEZ) has 82 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.6M shares
of 104M outstanding shares and own 26.6% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (5.54M shares), Saba Capital Management, L.P. (4.48M shares), BANK OF AMERICA CORP /DE/ (2.55M shares), UBS Group AG (2.18M shares), RIVERNORTH CAPITAL MANAGEMENT, LLC (1.64M shares), Invesco Ltd. (1.62M shares), 1607 Capital Partners, LLC (1.57M shares), WELLS FARGO & COMPANY/MN (1.05M shares), Karpus Management, Inc. (823K shares), and Cornerstone Advisors, LLC (816K shares).
This table shows the top 82 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.